Tau-话题@MedSci

#Tau#

137篇内容 | 3557人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1509302, encodeId=022f150930288, content=<a href='/topic/show?id=19791e14471' target=_blank style='color:#2F92EE;'>#Tau#</a>, objectTitle=NMPA批准针对痴呆症的18F-APN-1607 Tau PET成像示踪剂的III期临床试验, objectType=article, longId=202653, objectId=fcf72026535d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fcf72026535d, replyNumber=0, likeNumber=55, createdTime=2020-10-31, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fcf72026535d, moduleTitle=NMPA批准针对痴呆症的18F-APN-1607 Tau PET成像示踪剂的III期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fcf72026535d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509301, encodeId=6d70150930120, content=<a href='/topic/show?id=19791e14471' target=_blank style='color:#2F92EE;'>#Tau#</a>, objectTitle=Acta Neuropathologica: 蓝斑变性是tau病的一个常见特征，与额颞叶变性谱中的TDP-43蛋白病变不同, objectType=article, longId=202167, objectId=40eb20216ef2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40eb20216ef2, replyNumber=0, likeNumber=62, createdTime=2020-10-17, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40eb20216ef2, moduleTitle=Acta Neuropathologica: 蓝斑变性是tau病的一个常见特征，与额颞叶变性谱中的TDP-43蛋白病变不同, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=40eb20216ef2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509300, encodeId=c42415093003f, content=<a href='/topic/show?id=19791e14471' target=_blank style='color:#2F92EE;'>#Tau#</a>, objectTitle=Acta Neuropathologica: MAP激酶p38γ降低tau介导的晚期记忆缺陷, objectType=article, longId=201974, objectId=a7412019e4df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7412019e4df, replyNumber=0, likeNumber=49, createdTime=2020-10-12, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7412019e4df, moduleTitle=Acta Neuropathologica: MAP激酶p38γ降低tau介导的晚期记忆缺陷, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a7412019e4df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509299, encodeId=41d31509299b2, content=<a href='/topic/show?id=19791e14471' target=_blank style='color:#2F92EE;'>#Tau#</a>, objectTitle=挑战25年来的共识！阿尔兹海默症疫苗即将开展III期临床，这家公司剑指tau蛋白阿喀琉斯之踵, objectType=article, longId=200686, objectId=c99d2006862e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c99d2006862e, replyNumber=0, likeNumber=77, createdTime=2020-09-16, rootId=0, userName=szhvet, userId=55c610090940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c99d2006862e, moduleTitle=挑战25年来的共识！阿尔兹海默症疫苗即将开展III期临床，这家公司剑指tau蛋白阿喀琉斯之踵, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c99d2006862e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509298, encodeId=f13e1509298e6, content=<a href='/topic/show?id=19791e14471' target=_blank style='color:#2F92EE;'>#Tau#</a>, objectTitle=Acta Neuropathologica: 血浆p-tau 181至少在死亡前8年能准确预测阿尔茨海默病的病理并且改善认知功能衰退的临床特征, objectType=article, longId=200579, objectId=eb822005e987, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb822005e987, replyNumber=0, likeNumber=65, createdTime=2020-09-13, rootId=0, userName=szhvet, userId=55c610090940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb822005e987, moduleTitle=Acta Neuropathologica: 血浆p-tau 181至少在死亡前8年能准确预测阿尔茨海默病的病理并且改善认知功能衰退的临床特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb822005e987)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509297, encodeId=6185150929ee9, content=<a href='/topic/show?id=19791e14471' target=_blank style='color:#2F92EE;'>#Tau#</a>, objectTitle=Acta Neuropathologica: SFPQ和Tau：导致阿尔茨海默病快速发展的关键因素, objectType=article, longId=200488, objectId=b6b620048865, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6b620048865, replyNumber=0, likeNumber=53, createdTime=2020-09-11, rootId=0, userName=szhvet, userId=55c610090940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6b620048865, moduleTitle=Acta Neuropathologica: SFPQ和Tau：导致阿尔茨海默病快速发展的关键因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6b620048865)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509296, encodeId=47f315092964f, content=<a href='/topic/show?id=19791e14471' target=_blank style='color:#2F92EE;'>#Tau#</a>, objectTitle=阿尔兹海默症疗法深度报告：从淀粉样蛋白、Tau蛋白药物到干细胞、基因疗法, objectType=article, longId=200487, objectId=c50620048e44, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c50620048e44, replyNumber=0, likeNumber=69, createdTime=2020-09-11, rootId=0, userName=szhvet, userId=55c610090940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c50620048e44, moduleTitle=阿尔兹海默症疗法深度报告：从淀粉样蛋白、Tau蛋白药物到干细胞、基因疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c50620048e44)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509295, encodeId=1d0b15092959f, content=<a href='/topic/show?id=19791e14471' target=_blank style='color:#2F92EE;'>#Tau#</a>, objectTitle=Acta Neuropathologica：慢性创伤性脑病(CTE)中tau沉积特征：McKee-CTE分期方案的应用, objectType=article, longId=199807, objectId=1ff419980efb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ff419980efb, replyNumber=0, likeNumber=64, createdTime=2020-08-23, rootId=0, userName=szhvet, userId=55c610090940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ff419980efb, moduleTitle=Acta Neuropathologica：慢性创伤性脑病(CTE)中tau沉积特征：McKee-CTE分期方案的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ff419980efb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509294, encodeId=b35515092949e, content=<a href='/topic/show?id=19791e14471' target=_blank style='color:#2F92EE;'>#Tau#</a>, objectTitle=JAMA：血浆P-tau217水平是鉴别阿尔茨海默病的重要生物标志物, objectType=article, longId=198357, objectId=c54f19835e78, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c54f19835e78, replyNumber=0, likeNumber=80, createdTime=2020-07-31, rootId=0, userName=szhvet, userId=55c610090940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c54f19835e78, moduleTitle=JAMA：血浆P-tau217水平是鉴别阿尔茨海默病的重要生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c54f19835e78)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509293, encodeId=91ca1509293c7, content=<a href='/topic/show?id=19791e14471' target=_blank style='color:#2F92EE;'>#Tau#</a>, objectTitle=Acta Neuropathologica:进行性核上性麻痹中tau蛋白病理的分布模式, objectType=article, longId=197839, objectId=55a319e8398b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55a319e8398b, replyNumber=0, likeNumber=67, createdTime=2020-07-22, rootId=0, userName=szhvet, userId=55c610090940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55a319e8398b, moduleTitle=Acta Neuropathologica:进行性核上性麻痹中tau蛋白病理的分布模式, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55a319e8398b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509292, encodeId=7b33150929264, content=<a href='/topic/show?id=19791e14471' target=_blank style='color:#2F92EE;'>#Tau#</a>, objectTitle=Nat Commun：自噬激活药物可长期清除阿尔兹海默相关tau蛋白, objectType=article, longId=196679, objectId=aafa1966e9b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aafa1966e9b8, replyNumber=0, likeNumber=60, createdTime=2020-06-30, rootId=0, userName=szhvet, userId=55c610090940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aafa1966e9b8, moduleTitle=Nat Commun：自噬激活药物可长期清除阿尔兹海默相关tau蛋白, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aafa1966e9b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509291, encodeId=c25815092912f, content=<a href='/topic/show?id=19791e14471' target=_blank style='color:#2F92EE;'>#Tau#</a>, objectTitle=Nat Med：Tau的分子多样性使得阿尔茨海默病具有临床异质性 , objectType=article, longId=196666, objectId=9a8319666637, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a8319666637, replyNumber=0, likeNumber=59, createdTime=2020-06-30, rootId=0, userName=szhvet, userId=55c610090940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a8319666637, moduleTitle=Nat Med：Tau的分子多样性使得阿尔茨海默病具有临床异质性 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a8319666637)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509290, encodeId=4c2d150929011, content=<a href='/topic/show?id=19791e14471' target=_blank style='color:#2F92EE;'>#Tau#</a>, objectTitle=Nat Commun：阿尔兹海默病中，tau蛋白可通过交流神经元传播, objectType=article, longId=196315, objectId=78df19631545, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78df19631545, replyNumber=0, likeNumber=71, createdTime=2020-06-25, rootId=0, userName=szhvet, userId=55c610090940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78df19631545, moduleTitle=Nat Commun：阿尔兹海默病中，tau蛋白可通过交流神经元传播, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78df19631545)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509289, encodeId=c60f15092897f, content=<a href='/topic/show?id=19791e14471' target=_blank style='color:#2F92EE;'>#Tau#</a>, objectTitle=FDA批准Tau放射性诊断剂Tauvid用于阿尔茨海默症, objectType=article, longId=194973, objectId=f4ed1949e35d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4ed1949e35d, replyNumber=0, likeNumber=58, createdTime=2020-05-31, rootId=0, userName=szhvet, userId=55c610090940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4ed1949e35d, moduleTitle=FDA批准Tau放射性诊断剂Tauvid用于阿尔茨海默症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f4ed1949e35d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509288, encodeId=8415150928810, content=<a href='/topic/show?id=19791e14471' target=_blank style='color:#2F92EE;'>#Tau#</a>, objectTitle=JAMA Neurol：tau-PET示踪剂RO948 F18对阿尔茨海默病具有极高的鉴别能力, objectType=article, longId=194781, objectId=ae71194e811b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae71194e811b, replyNumber=0, likeNumber=0, createdTime=2020-05-28, rootId=0, userName=szhvet, userId=55c610090940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae71194e811b, moduleTitle=JAMA Neurol：tau-PET示踪剂RO948 F18对阿尔茨海默病具有极高的鉴别能力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae71194e811b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509287, encodeId=3ee8150928ed7, content=<a href='/topic/show?id=19791e14471' target=_blank style='color:#2F92EE;'>#Tau#</a>, objectTitle=JAMA Neurol:[18F]flortaucipir PET在AD神经病理学改变检测中的应用, objectType=article, longId=193198, objectId=b23119319828, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b23119319828, replyNumber=0, likeNumber=92, createdTime=2020-05-01, rootId=0, userName=szhvet, userId=55c610090940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b23119319828, moduleTitle=JAMA Neurol:[18F]flortaucipir PET在AD神经病理学改变检测中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b23119319828)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509286, encodeId=1fb01509286b3, content=<a href='/topic/show?id=19791e14471' target=_blank style='color:#2F92EE;'>#Tau#</a>, objectTitle=NATURE：阿尔兹海默症中tau蛋白主要通过LRP1传播, objectType=article, longId=191362, objectId=27dc19136285, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27dc19136285, replyNumber=0, likeNumber=64, createdTime=2020-04-05, rootId=0, userName=szhvet, userId=55c610090940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27dc19136285, moduleTitle=NATURE：阿尔兹海默症中tau蛋白主要通过LRP1传播, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27dc19136285)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509285, encodeId=584a1509285d5, content=<a href='/topic/show?id=19791e14471' target=_blank style='color:#2F92EE;'>#Tau#</a>, objectTitle=芬氟拉明治疗Lennox-Gastaut综合征的III期临床试验取得积极结果, objectType=article, longId=187677, objectId=e89218e67760, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e89218e67760, replyNumber=0, likeNumber=30, createdTime=2020-02-09, rootId=0, userName=szhvet, userId=55c610090940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e89218e67760, moduleTitle=芬氟拉明治疗Lennox-Gastaut综合征的III期临床试验取得积极结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e89218e67760)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509284, encodeId=96371509284c9, content=<a href='/topic/show?id=19791e14471' target=_blank style='color:#2F92EE;'>#Tau#</a>, objectTitle=JAMA Neurol：APOE4、Aβ以及tau蛋白的相关性研究, objectType=article, longId=185258, objectId=512818525860, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=512818525860, replyNumber=0, likeNumber=69, createdTime=2019-12-27, rootId=0, userName=szhvet, userId=55c610090940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=512818525860, moduleTitle=JAMA Neurol：APOE4、Aβ以及tau蛋白的相关性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=512818525860)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509283, encodeId=ac7815092833f, content=<a href='/topic/show?id=19791e14471' target=_blank style='color:#2F92EE;'>#Tau#</a>, objectTitle=Biogen以4500万美元收购Ionis早期阿尔茨海默氏症药物--靶向tau蛋白, objectType=article, longId=185043, objectId=660818504339, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=660818504339, replyNumber=0, likeNumber=64, createdTime=2019-12-23, rootId=0, userName=szhvet, userId=55c610090940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=660818504339, moduleTitle=Biogen以4500万美元收购Ionis早期阿尔茨海默氏症药物--靶向tau蛋白, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=660818504339)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Tau

2020-05-29

hb2008ye (审核中...)

前往app查看评论内容

#Tau#

NMPA批准针对痴呆症的18F-APN-1607 Tau PET成像示踪剂的III期临床试验

2020-10-31

hb2008ye (审核中...)

前往app查看评论内容

#Tau#

Acta Neuropathologica: 蓝斑变性是tau病的一个常见特征，与额颞叶变性谱中的TDP-43蛋白病变不同

2020-10-17

hb2008ye (审核中...)

前往app查看评论内容

#Tau#

Acta Neuropathologica: MAP激酶p38γ降低tau介导的晚期记忆缺陷

2020-10-12

szhvet (审核中...)

前往app查看评论内容

#Tau#

挑战25年来的共识！阿尔兹海默症疫苗即将开展III期临床，这家公司剑指tau蛋白阿喀琉斯之踵

2020-09-16

szhvet (审核中...)

前往app查看评论内容

#Tau#

Acta Neuropathologica: 血浆p-tau 181至少在死亡前8年能准确预测阿尔茨海默病的病理并且改善认知功能衰退的临床特征

2020-09-13

szhvet (审核中...)

前往app查看评论内容

#Tau#

Acta Neuropathologica: SFPQ和Tau：导致阿尔茨海默病快速发展的关键因素

2020-09-11

szhvet (审核中...)

前往app查看评论内容

#Tau#

阿尔兹海默症疗法深度报告：从淀粉样蛋白、Tau蛋白药物到干细胞、基因疗法

2020-09-11

szhvet (审核中...)

前往app查看评论内容

#Tau#

Acta Neuropathologica：慢性创伤性脑病(CTE)中tau沉积特征：McKee-CTE分期方案的应用

2020-08-23

szhvet (审核中...)

前往app查看评论内容

#Tau#

JAMA：血浆P-tau217水平是鉴别阿尔茨海默病的重要生物标志物

2020-07-31

szhvet (审核中...)

前往app查看评论内容

#Tau#

Acta Neuropathologica:进行性核上性麻痹中tau蛋白病理的分布模式

2020-07-22

szhvet (审核中...)

前往app查看评论内容

#Tau#

Nat Commun：自噬激活药物可长期清除阿尔兹海默相关tau蛋白

2020-06-30

szhvet (审核中...)

前往app查看评论内容

#Tau#

Nat Med：Tau的分子多样性使得阿尔茨海默病具有临床异质性

2020-06-30

szhvet (审核中...)

前往app查看评论内容

#Tau#

Nat Commun：阿尔兹海默病中，tau蛋白可通过交流神经元传播

2020-06-25

szhvet (审核中...)

前往app查看评论内容

#Tau#

FDA批准Tau放射性诊断剂Tauvid用于阿尔茨海默症

2020-05-31

szhvet (审核中...)

前往app查看评论内容

#Tau#

JAMA Neurol：tau-PET示踪剂RO948 F18对阿尔茨海默病具有极高的鉴别能力

2020-05-28

szhvet (审核中...)

前往app查看评论内容

#Tau#

JAMA Neurol:[18F]flortaucipir PET在AD神经病理学改变检测中的应用

2020-05-01

szhvet (审核中...)

前往app查看评论内容

#Tau#

NATURE：阿尔兹海默症中tau蛋白主要通过LRP1传播

2020-04-05

szhvet (审核中...)

前往app查看评论内容

#Tau#

芬氟拉明治疗Lennox-Gastaut综合征的III期临床试验取得积极结果

2020-02-09

szhvet (审核中...)

前往app查看评论内容

#Tau#

JAMA Neurol：APOE4、Aβ以及tau蛋白的相关性研究

2019-12-27

szhvet (审核中...)

前往app查看评论内容

#Tau#

Biogen以4500万美元收购Ionis早期阿尔茨海默氏症药物--靶向tau蛋白

2019-12-23

科室
- - 订阅+
  - 更多科室
工具
服务